KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) of ...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- In a new post-hoc analysis presented for the first time at the American Diabetes Association (ADA) 70 th Annual Scientific Sessions, significantly more ...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the primary results of the Trial Evaluating Cardiovascular Outcomes with ...

Merck Receives Positive CHMP Opinion for JANUVIA® (sitagliptin) and JANUMET® (sitagliptin/metformin) as Add-On to Insulin in the European Union WHITEHOUSE STATION ...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a late-breaking observational study that assessed the differences in time to initiation of insulin ...

Resource4thePeople announced today its latest update for consumers who are following the progress of lawsuits alleging that a class of diabetes medications including Januvia, Janumet, Byetta and ...

Sitagliptin is prescribed metformin januvia 50mg people who still have high blood sugar, even though they have a sensible diet and exercise regularly. It comes as tablets that you swallow. Common side ...

Silver Spring, MD -The US Food and Drug Administration (FDA) announced that it is revising prescribing information for diabetes drugs sitagliptin (Januvia, Merck) and sitagliptin/metformin (Janumet, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Switching to the glucagon-like peptide-1 ...

The two incretin hormones, glucagon-like peptide (GLP)-1 and glucose-dependent insulinotropic polypeptide potentiate nutrient-dependent insulin secretion following meal ingestion. Metabolic control ...